Genmab, an international biotechnology company specialising in the creation and development of differentiated antibody therapeutics for the treatment of cancer, has adopted the Genedata Biopharma Platform to support their global oncology programs.
The Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) recently announced it had been awarded federal funding for a new building which will provide a new research centre to investigate how interactions among microbes, water, soil, and plants shape entire ecosystems
Integrated DNA Technologies (IDT) has announced that it is teaming up with 3CR Bioscience (3CR) to widen access to quality custom solutions for genotyping screening
IDBS’ E-WorkBook has been implemented by Solvay, an advanced materials and speciality chemicals company, as part of a digital transformation project that has removed paper-based processes across the organisation
Integrated DNA Technologies (IDT) has announced an expansion to its next generation sequencing (NGS portfolio) with the launch of Custom NGS Adapters that are designed to provide an easy and flexible customised adapter solution directly to scientists
BioCity, a life science incubator and business collective, has announced investment in INCUS Performance. Founded in 2016, INCUS Performance is a sports technology start-up that is helping athletes to train better using data
Integrated DNA Technologies (IDT) has announced that it is once again partnering with the International Genetically Engineered Machine (iGEM) Foundation to support young researchers and promote scientific progress.
The American College of Radiology (ACR) Data Science Institute (DSI) has launched its ACR AI-LAB software platform securing GE Healthcare as a key collaborator
The latest release of Matereality Version 12 software can be used in conjunction with eLim, a new bolt-on for companies to manage and operate their test labs
ACD/Labs has announced the launch of a new web-based application in support of high throughput (HT) experimentation. Katalyst D2D offers a single interface for high throughput experimentation and parallel synthesis
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
